Samtidig administration af ENGERIX B og en standarddosis af HBIg medfører ikke lavere anti- HB antistoftitre, forudsat de indgives på separate injektionssteder.
The simultaneous administration of ENGERIX B and a standard dose of HBIg does not result in lower anti-HBs antibody titres provided that they are administered at separate injection sites.